Available under Open Access Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised… Read more BMJ meta-analysis: optimal DAPT duration after PCI with DES

Available under Open Access Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised… Read more BMJ meta-analysis: optimal DAPT duration after PCI with DES
Open Heart 2014;1: doi:10.1136/openhrt-2014-000064 First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of… Read more First-generation versus second-generation drug-eluting stents in current clinical practice
Available under Open Access Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus… Read more BMJ LATEST RESEARCH: SIRIO MEDICINE’S network meta-analysis
A new study has revealed that statins can increase the risk of developing type 2 diabetes and that this risk… Read more Different types and doses of statins affect risk of new-onset diabetes
Low molecular weight heparin in patients with acute myocardial infarction significantly reduces the frequency of major bleeding and reduces by half… Read more Cardiologists change the European Guidelines of the treatment of acute myocardial infarction
Manual vs mechanical thrombectomy during PCI for STEMI: a comprehensive direct and adjusted indirect meta-analysis of randomized trials Am J Cardiovasc Dis… Read more Manual vs mechanical thrombectomy during PCI for STEMI
Meta-analysis assessing the clinical efficacy and safety of the lowest doses of oral factor Xa inhibitors in patients who recently underwent acute… Read more Low-dose of oral factor Xa inhibitors in patients with a recent ACS
Meta-analysis striving to answer which is the best moment to start the invasive therapy in non-ST ACS patients. Optimal timing… Read more Optimal timing of coronary invasive strategy in non-ST-segment elevation ACS